comparemela.com

Latest Breaking News On - Bay capital management - Page 1 : comparemela.com

Vicarious Surgical (NYSE:RBOT) Shares Set to Reverse Split on Thursday, June 13th

Vicarious Surgical Inc (NYSE:RBOT – Free Report)’s stock is scheduled to reverse split on the morning of Thursday, June 13th. The 1-30 reverse split was announced on Thursday, June 13th. The number of shares owned by shareholders will be adjusted after the closing bell on Thursday, June 13th. Vicarious Surgical Trading Down 18.9 % Shares […]

Energy Services of America Co (NASDAQ:ESOA) President Douglas V Reynolds Buys 2,000 Shares

Energy Services of America Co. (NASDAQ:ESOA – Get Free Report) President Douglas V. Reynolds acquired 2,000 shares of the company’s stock in a transaction dated Friday, June 7th. The stock was purchased at an average cost of $7.15 per share, with a total value of $14,300.00. Following the completion of the purchase, the president now […]

Vicarious Surgical (NYSE:RBOT) Shares Scheduled to Reverse Split on Thursday, June 13th

Vicarious Surgical Inc (NYSE:RBOT – Free Report)’s stock is going to reverse split before the market opens on Thursday, June 13th. The 1-30 reverse split was announced on Thursday, June 13th. The number of shares owned by shareholders will be adjusted after the market closes on Thursday, June 13th. Vicarious Surgical Trading Down 18.9 % […]

Redwood Investment Management LLC Boosts Stock Holdings in Bausch Health Companies Inc (NYSE:BHC)

Redwood Investment Management LLC increased its position in shares of Bausch Health Companies Inc. (NYSE:BHC – Free Report) by 3.7% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 401,495 shares of the company’s stock after purchasing an additional 14,184 shares during the quarter. Redwood Investment Management […]

Seven Eight Capital LP Purchases 26,831 Shares of Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)

Seven Eight Capital LP increased its position in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 140.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 45,906 shares of the biopharmaceutical company’s stock after purchasing an additional 26,831 shares during the […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.